FreeThink Technologies, Inc., presented among a panel of well-known scientists, at the
FreeThink’s very own Dr. Maria Krisch, joined other panelists and speakers from AstraZeneca, GlaxoSmithKline, Pfizer & Clarivate Analytics.
Continuing in the successful series of “Stability Meetings” topics included the management and assessment of drug stability from those involved in regulation, inspection of stability and GDP. These industry experts gathered to learn about scientific developments and stability study design and interpretation. The conference included